Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Chronic Emphysema(Archived)

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Chronic Emphysema(Archived)

Joe Devasahayam et al.
Free Books & Documents

Excerpt

Pulmonary emphysema is defined as a pathological, permanent dilatation of distal airways (respiratory bronchioles, alveolar ducts, and alveolar sacs) due to the destruction of the walls of the airways without fibrotic changes. Emphysema destroys the essential ventilatory units and interrupts the gas exchange. Functionally, emphysema causes obstructive ventilatory defect evidenced in the spirometry and is included in the collective diseases of chronic obstructive pulmonary disease, commonly termed as COPD. Advanced emphysema is a common and serious cause of chronic respiratory failure and acute decompensation that could be life-threatening. Due to its high morbidity and mortality, recognizing and treating this condition in its early stages is vital. Emphysema is differentiated from interstitial pneumonia by the absence of fibrosis of the pulmonary interstitium. Notwithstanding, combined pulmonary fibrosis and emphysema (CPFE) has been documented as a separate clinical entity, in many patients with proven emphysema. Repeated exacerbations of emphysema and subsequent decompensation cause a rapid decline in lung function greater than expected from age.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Joe Devasahayam declares no relevant financial relationships with ineligible companies.

Disclosure: Kilian LaFreniere declares no relevant financial relationships with ineligible companies.

Disclosure: Roopa Naik declares no relevant financial relationships with ineligible companies.

References

    1. GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017 Sep;5(9):691-706. - PMC - PubMed
    1. Alsumrain M, De Giacomi F, Nasim F, Koo CW, Bartholmai BJ, Levin DL, Moua T. Combined pulmonary fibrosis and emphysema as a clinicoradiologic entity: Characterization of presenting lung fibrosis and implications for survival. Respir Med. 2019 Jan;146:106-112. - PubMed
    1. Thomson NC. Challenges in the management of asthma associated with smoking-induced airway diseases. Expert Opin Pharmacother. 2018 Oct;19(14):1565-1579. - PubMed
    1. Peiffer G, Underner M, Perriot J, Dalphin JC. [COPD: think about occupational exposures!]. Rev Prat. 2018 Jan;68(1):74-78. - PubMed
    1. Chardon ML, Dalphin JC, Degano B. [Pneumothorax in young cannabis smokers: A propos of three cases]. Rev Mal Respir. 2018 May;35(5):556-561. - PubMed

Publication types

LinkOut - more resources